Biofilms in Orthopaedic Infections

Biofilm Basics - Slimy Strongholds

• Definition: Structured microbial communities encased in a self-produced Extracellular Polymeric Substance (EPS).
• EPS Matrix: Primarily polysaccharides, proteins, extracellular DNA (eDNA), and lipids. Acts as a protective barrier.
• Key Features:
  • Adherence: To implants (metal, polymer) & host tissues.
  • Protection: Shields bacteria from host immune cells (phagocytes) & antibiotics.
  • Resistance: Can exhibit ↑ 100-1000x antibiotic tolerance vs. planktonic forms.
  • Communication: Quorum sensing coordinates biofilm behavior.
• Orthopaedic Significance: Critical in prosthetic joint infections (PJI), fracture-related infections (FRI), and chronic osteomyelitis.

⭐ Biofilms contain "persister cells," dormant variants highly tolerant to antibiotics, contributing to infection recurrence after treatment cessation and implant retention attempts.

Biofilm Formation - The Attachment Story

• Attachment (Steps 1-3 in flowchart):
  • Initial: Planktonic cells, reversible (Van der Waals forces).
  • Irreversible: Adhesins (e.g., MSCRAMMs), pili; aided by host conditioning film (e.g., fibronectin).
• Development (Steps 4-5):
  • Microcolonies: Bacterial aggregation, EPS (Exopolysaccharide) matrix production.
  • Maturation: Complex 3D structure, intercellular communication via quorum sensing.
• Dispersal (Step 6):
  • Enzymatic degradation of EPS matrix, release of planktonic bacteria.

⭐ Key adhesins for Staphylococcus aureus include MSCRAMMs (e.g., FnBPA/B binding fibronectin), crucial for initial attachment to implant surfaces conditioned by host proteins.

Biofilm Pathogenesis - Resistance & Evasion

• Physical Barrier: Extracellular Polymeric Substance (EPS) matrix.
  • Limits antibiotic penetration (diffusion barrier).
  • Shields from host immune cells (phagocytes, antibodies).
• Altered Microenvironment:
  • Slow bacterial growth rate (↓ metabolic activity) → ↓ antibiotic efficacy.
  • Nutrient/oxygen gradients → dormant persister cells.
  • Acidic pH, ↑ $CO_2$, ↓ $O_2$.
• Persister Cells:
  • Metabolically dormant, highly antibiotic-tolerant (not resistant).
  • Can repopulate biofilm after antibiotic course.
• Resistance Mechanisms:
  • Concentration of antibiotic-degrading enzymes (e.g., β-lactamases) in EPS.
  • Upregulation of efflux pumps.
  • Horizontal gene transfer (HGT) of resistance genes facilitated by close proximity.
• Immune Evasion:
  • EPS hides bacterial PAMPs (Pathogen-Associated Molecular Patterns).
  • Inhibits phagocytosis & complement activation.
  • Quorum sensing coordinates defense mechanisms.

⭐ Biofilms can exhibit 10-1000 times more resistance to antimicrobial agents compared to their planktonic (free-floating) counterparts. This is a key reason for chronic and recurrent orthopaedic infections.

Biofilm Management - Diagnosis & Attack

Diagnosis:

• Clinical: Chronic, low-grade, implant-associated.
• Microbiology:
  • Sonication of explants ↑yield.
  • Prolonged culture (up to 14 days).
  • Molecular methods (16S rRNA PCR).
• Imaging: X-ray, MRI; PET-CT (metabolic activity).
• Biomarkers: Synovial α-defensin, leukocyte esterase.

Attack Strategies:

• Surgical: Cornerstone. Aggressive debridement of infected tissue.
• Implant strategy: DAIR (early <4 wks, stable implant), 1/2-stage exchange (chronic).
• Antimicrobial Therapy:
  • Biofilm-active agents (Rifampicin, Daptomycin).
  • Combination therapy essential.
  • Prolonged duration (4-6 wks IV, then oral).
  • High local delivery (antibiotic spacers).
• Novel (adjunctive): QS inhibitors, phage therapy.

⭐ Rifampicin is highly effective against staphylococcal biofilms but must ALWAYS be used in combination (e.g., with a fluoroquinolone or fusidic acid) to prevent rapid emergence of resistance.

High‑Yield Points - ⚡ Biggest Takeaways

• Biofilms: Structured bacterial communities in self-produced EPS matrix, adhering to implants & devitalized tissue.
• Central to chronic orthopaedic infections like PJI & implant-associated osteomyelitis.
• Exhibit ↑ antibiotic resistance due to EPS barrier & altered bacterial metabolic states.
• Diagnosis: Sonication of explanted hardware or multiple intraoperative tissue cultures.
• Treatment: Thorough surgical debridement, implant removal/exchange, plus prolonged systemic antibiotics.
• Quorum sensing regulates biofilm formation, offering novel therapeutic targets.